Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Exp Cell Res ; 319(4): 536-45, 2013 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-23246570

RESUMO

Epidemiological studies report a negative association between circulating bilirubin concentrations and the risk for cancer and cardiovascular disease. Structurally related tetrapyrroles also possess in vitro anti-genotoxic activity and may prevent mutation prior to malignancy. Furthermore, few data suggest that tetrapyrroles exert anti-carcinogenic effects via induction of cell cycle arrest and apoptosis. To further investigate whether tetrapyrroles provoke DNA-damage in human cancer cells, they were tested in the single cell gel electrophoresis assay (SCGE). Eight tetrapyrroles (unconjugated bilirubin, bilirubin ditaurate, biliverdin, biliverdin-/bilirubin dimethyl ester, urobilin, stercobilin and protoporphyrin) were added to cultured Caco2 and HepG2 cells and their effects on comet formation (% tail DNA) were assessed. Flow cytometric assessment (apoptosis/necrosis, cell cycle, intracellular radical species generation) assisted in revealing underlying mechanisms of intracellular action. Cells were incubated with tetrapyrroles at concentrations of 0.5, 5 and 17µM for 24h. Addition of 300µM tertiary-butyl hydroperoxide to cells served as a positive control. Tetrapyrrole incubation mostly resulted in increased DNA-damage (comet formation) in Caco2 and HepG2 cells. Tetrapyrroles that are concentrated within the intestine, including protoporphyrin, urobilin and stercobilin, led to significant comet formation in both cell lines, implicating the compounds in inducing DNA-damage and apoptosis in cancer cells found within organs of the digestive system.


Assuntos
Dano ao DNA/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Neoplasias/patologia , Tetrapirróis/metabolismo , Tetrapirróis/farmacologia , Antioxidantes/farmacologia , Pigmentos Biliares/farmacologia , Bilirrubina/análogos & derivados , Bilirrubina/farmacologia , Células CACO-2 , Ensaio Cometa , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Citometria de Fluxo , Células Hep G2 , Humanos , Neoplasias/genética , Concentração Osmolar , Protoporfirinas/farmacologia , Urobilina/farmacologia
2.
Biochim Biophys Acta ; 1076(3): 369-73, 1991 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-1848104

RESUMO

We studied the effect of bilirubin on the NADPH-dependent superoxide production induced by sodium dodecyl sulfate in a cell-free system consisting of the membrane and cytosolic fractions of pig neutrophils. Preincubation of the cytosolic fraction with bilirubin before the addition of sodium dodecyl sulfate resulted in the time- and dose-dependent inhibition of the superoxide production while the preincubation of the membrane fraction with the tetrapyrrole did not result in the inhibition. When the pigment was added after the initiation of the reaction, the ongoing production was not affected by the addition. Other tetrapyrroles, such as hemin, protoporphyrin and biliverdin, also inhibited the production. The results indicate that bilirubin inhibits the activation process of the superoxide producing NADPH oxidase by decreasing the potency of the cytosolic fraction and its inhibitory effect seems to be due to the hydrophobic nature of the tetrapyrrole.


Assuntos
Bilirrubina/farmacologia , NADH NADPH Oxirredutases/sangue , NADPH Oxidases , Neutrófilos/enzimologia , Superóxidos/sangue , Animais , Biliverdina/farmacologia , Membrana Celular/enzimologia , Sistema Livre de Células , Citosol/enzimologia , Heme/farmacologia , Cinética , NADH NADPH Oxirredutases/antagonistas & inibidores , Protoporfirinas/farmacologia , Suínos , Urobilina/farmacologia
3.
Microbiol Immunol ; 36(4): 381-90, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1328826

RESUMO

Biliverdin (BV), a bile pigment, was examined for its antiviral activity against human herpesvirus-6 (HHV-6) in vitro. BV (10 micrograms/ml) markedly inhibited HHV-6 replication in MT-4 cells when the cells were treated during a virus adsorption period. Its antiviral effect was weakened when cells were treated after adsorption. Treatment of cells with BV (40 micrograms/ml) 3 hr after virus infection had no inhibitory effect on virus replication. Virus replication was also significantly inhibited by treatment of MT-4 cells with BV (10 micrograms/ml) before infection, while the virions were not inactivated by BV (20 micrograms/ml). Bilirubin and urobilin, metabolic derivatives of BV, showed slight inhibitory effects on virus replication in the cells. On the other hand, BV had no potent inhibitory activity in the replication of herpes simplex virus-1 or human cytomegalovirus. These observations suggest that BV could interact with MT-4 cells to inhibit an early stage of HHV-6 infection in a virus-specific manner.


Assuntos
Biliverdina/farmacologia , Infecções por Herpesviridae/tratamento farmacológico , Herpesvirus Humano 6/efeitos dos fármacos , Animais , Bilirrubina/farmacologia , Bilirrubina/toxicidade , Biliverdina/toxicidade , Relação Dose-Resposta a Droga , Estudos de Avaliação como Assunto , Humanos , Urobilina/farmacologia , Urobilina/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA